ReRx Therapeutics

ReRx Therapeutics

生物技术研究

Transforming clinical outcomes of patients with severe metabolic disorder

关于我们

ReRx is developing novel, oral therapeutics to treat patients with severe metabolic diseases including obesity, metabolic syndrome, diabetes, and liver diseases. Our therapeutics target metabolic pathways involved in regulating energy homeostasis and improve treatment outcomes compared to similar pharmacological agents. ReRx is part of the Berkeley SkyDeck Cohort 17 (https://skydeck.berkeley.edu).

网站
https://www.rerxtherapeutics.com
所属行业
生物技术研究
规模
2-10 人
类型
私人持股

ReRx Therapeutics员工

动态

相似主页